Skip to main content

Table 1 Clinical features of subungual benign melanocytic proliferation and subungual melanoma in situ

From: Cyclin D1 and PRAME expression in distinguishing melanoma in situ from benign melanocytic proliferation of the nail unit

Features

Subungual benign melanocytic proliferation (n = 14), n (%)

Subungual Melanoma in situ (n = 13), n (%)

p-value

Sex

  

0.842

 Male

7 (50)

7 (53.8)

 

 Female

7 (50)

6 (46.2)

Age, years

  

0.061

 Range

7-66

6-74

 

 Mean ± SD

30.71 ± 19.83

44.92 ± 17.73

Onset age, years

  

0.048a

 Range

4-56

5-64

 

 Mean ± SD

25.71 ± 15.97

39.46 ± 17.16

Prediagnosis duration, months

  

0.756

 Range

8-240

6-180

 

 Mean ± SD

59.21 ± 67.27

66.62 ± 64.12

Location

  

0.385

 Finger

12 (85.7)

9 (69.2)

 

 Toe

2 (14.3)

4 (30.8)

Width, mm

  

0.017a

 Range

1.00-13.00

1.50-15.00

 

 Mean ± SD

3.39 ± 2.90

7.81 ± 4.87

Background pigmentation

  

1.000

 Yes

11 (78.6)

11 (84.6)

 

 No

3 (21.4)

2 (15.4)

Nail dystrophy

  

0.596

 Yes

0 (0.0)

2 (15.4)

 

 No

14 (100.0)

11 (84.6)

Periungual pigmentation

  

0.568

 Yes

6 (42.9)

7 (53.8)

 

 No

8 (57.1)

6 (46.2)

  1. aStatistically significant